IGF2BP2 and cervical cancer: In summary, we unraveled a previously unknown molecular mechanism by which Th17 cells promote tumor progression under hypoxic conditions and suggest evaluation of Th17 cells as well as IGF2BP2 as potential target for therapeutic approaches in cervical cancer.